MDMA
Latest
FDA approves new trials using MDMA to help treat PTSD
MDMA, the pure form of Ecstasy, is usually only mentioned when partygoers get busted for holding the Schedule 1 restricted drug. But medical researchers have been quietly testing its potential medical applications, like treating terminally ill patients and assisting patient therapy for PTSD. The results from the latter have been promising enough for the FDA to commission Phase 3 trials, which is the last step before MDMA's possible approval as a prescription drug.
DEA approves MDMA study for the terminally ill
MDMA is widely used both on and off festival grounds. But the drug is quietly making a comeback as a therapeutic aid. Last week, the DEA approved a clinical trial that will use a combination of the psychedelic drug and psychotherapy to treat anxiety associated with terminal illnesses. Multidisciplinary Association for Psychedelic Studies (MAPS) has initiated the study as part of their on-going efforts to validate the effectiveness of MDMA in a scientific setting. This isn't the first time it's been used to assist psychotherapy. But if the study is successful, it will introduce a new use for the drug.
